238 related articles for article (PubMed ID: 32532830)
1. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.
Liu Y; Kaur S; Huang Y; Fahrmann JF; Rinaudo JA; Hanash SM; Batra SK; Singhi AD; Brand RE; Maitra A; Haab BB
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2513-2523. PubMed ID: 32532830
[TBL] [Abstract][Full Text] [Related]
2. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
3. Adding Rigor to Biomarker Evaluations-EDRN Experience.
Feng Z; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
[TBL] [Abstract][Full Text] [Related]
4. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
5. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Kammer MN; Deppen SA; Antic S; Jamshedur Rahman SM; Eisenberg R; Maldonado F; Aldrich MC; Sandler KL; Landman B; Massion PP; Grogan EL
Cancer Biomark; 2022; 33(4):449-465. PubMed ID: 35491773
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
Guo J; Xie K; Zheng S
Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
[TBL] [Abstract][Full Text] [Related]
7. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
8. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
9. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2524-2540. PubMed ID: 32699075
[TBL] [Abstract][Full Text] [Related]
10. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
12. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics: biomarkers of early detection.
Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
[TBL] [Abstract][Full Text] [Related]
15. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
16. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
17. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
[TBL] [Abstract][Full Text] [Related]
18. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA.
Ren AH; Fiala CA; Diamandis EP; Kulasingam V
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2568-2574. PubMed ID: 32277003
[TBL] [Abstract][Full Text] [Related]
20. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
